Prostate cancer mystery: why does targeted radiation fail?

NCT ID NCT05435495

First seen Mar 27, 2026 · Last updated May 16, 2026 · Updated 4 times

Summary

This study looks at why some prostate cancers do not respond to a type of targeted radiation therapy called PSMA radioligand therapy. Researchers will use scans and tumor samples from 125 people to measure radiation doses and check gene activity. The goal is to learn more about resistance, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Memorial Sloan Kettering

    RECRUITING

    New York, New York, 10065, United States

    Contact

    Contact

  • University of California, Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

    Contact

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.